UK markets closed

Insmed Incorporated (0JAV.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
23.73-1.75 (-6.86%)
At close: 07:14PM BST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.92
52-week change 356.58%
S&P500 52-week change 321.23%
52-week high 331.99
52-week low 316.58
50-day moving average 328.37
200-day moving average 324.95

Share statistics

Avg vol (3-month) 31.36k
Avg vol (10-day) 3254
Shares outstanding 577.09M
Implied shares outstanding 6N/A
Float 8147.09M
% held by insiders 11.09%
% held by institutions 1103.48%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -245.59%
Operating margin (ttm)-194.25%

Management effectiveness

Return on assets (ttm)-28.50%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)305.21M
Revenue per share (ttm)2.17
Quarterly revenue growth (yoy)41.10%
Gross profit (ttm)N/A
EBITDA -672.49M
Net income avi to common (ttm)-749.57M
Diluted EPS (ttm)-3.78
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)780.45M
Total cash per share (mrq)5.26
Total debt (mrq)1.36B
Total debt/equity (mrq)N/A
Current ratio (mrq)4.12
Book value per share (mrq)-2.24

Cash flow statement

Operating cash flow (ttm)-536.25M
Levered free cash flow (ttm)-384.98M